Caffeine vs DHT: The Science Behind Caffeine in Hair Serums

Caffeine in a hair serum sounds like a marketing decision. The biology of what it actually does to a DHT-suppressed hair follicle is a different conversation entirely. This article covers the mechanism, what the clinical evidence says, what caffeine cannot do on its own, and why it appears in two specific Radiance360 formulas.

ARTICLE SUMMARY

What does caffeine do to a hair follicle?  It inhibits phosphodiesterase, which raises cyclic AMP (cAMP) levels inside follicle cells. Higher cAMP promotes cell proliferation, counteracts some of DHT's suppressive effects, and extends the anagen growth phase.

Does it block DHT?  Not directly. It does not inhibit 5-alpha reductase the way Finasteride does. It operates downstream, partially reversing the effects DHT has already had on follicle cell activity.

What does the clinical evidence show?  A 2018 study in 210 men found that 0.2% topical caffeine produced results non-inferior to 5% Minoxidil over six months. A 2025 systematic review confirmed positive outcomes across all nine trials reviewed, though most had methodological limitations.

Which Radiance360 products contain it?  Xtra Hair Pro (Caffeine 0.05%) and Xtra Hair HER (Caffeine 0.2%). Both concentrations verified from the live product data.

Is it enough on its own?  No. For androgenetic alopecia where DHT is the primary driver, caffeine works well as a supporting ingredient within a formula but not as a standalone replacement for Minoxidil or Finasteride.

Why Would a Beverage Ingredient Have Any Effect on Hair Loss?

It is a fair thing to wonder. Caffeine is best known as the compound that keeps you awake, the molecule that billions of people consume in tea, coffee, and soft drinks every day. When it appears on a hair serum label, the natural reaction is to assume the brand is riding the association with energy and stimulation to make the product sound more appealing.

The actual mechanism has nothing to do with stimulation in the neurological sense. Caffeine's effect on the nervous system comes from its ability to block adenosine receptors in the brain. What it does inside a hair follicle is something different, and it is this separate mechanism that caught the attention of trichology researchers starting in the early 2000s.

Hair follicles are not nerve cells. They are complex, rapidly cycling mini-organs embedded in the scalp. Caffeine acts on them through a different pathway entirely, and the biology of that pathway is more interesting than the marketing version of the story usually suggests.

How Caffeine Works Inside the Hair Follicle

Step 1: Phosphodiesterase inhibition

Inside every cell, including follicle cells, a signalling molecule called cyclic adenosine monophosphate, or cAMP, acts as a key regulator of cellular activity. High cAMP levels signal cells to be active, to proliferate, and to maintain the anagen growth phase. An enzyme called phosphodiesterase (PDE) breaks down cAMP continuously, essentially switching off the growth signal.

Caffeine inhibits PDE. When PDE activity is suppressed, cAMP accumulates inside follicle cells. The cell receives a sustained growth signal rather than a degraded one. This extends the time follicle cells spend in active division, which directly translates into a longer anagen phase and thicker hair shaft production.

This is the primary mechanism behind caffeine's hair growth activity, and it is documented in peer-reviewed pharmacology literature, not just cosmetic marketing. A 2025 review published in Molecules (MDPI) confirmed that caffeine's interaction with adenosine pathways and the resulting increase in cAMP level is the central physiological mechanism driving follicle stimulation.

Step 2: Counteracting DHT's downstream effects

DHT shortens the anagen phase by suppressing cAMP pathways in genetically susceptible follicles. Androgen receptors activated by DHT trigger signalling cascades that reduce follicle cell proliferation and accelerate the transition to catagen (the regression phase). Caffeine's PDE-inhibiting effect partially counteracts this suppression by keeping cAMP active longer, even in the presence of elevated DHT.

The landmark Fischer et al. study using human scalp follicle organ culture demonstrated this directly. Follicles exposed to testosterone (which converts to DHT) showed suppressed growth. When caffeine at concentrations of 0.001% and 0.005% was added alongside testosterone, the suppressive effect was significantly counteracted. Hair shaft elongation increased, and the growth suppression from testosterone was partially reversed. This is not anecdote. It is controlled laboratory evidence using human tissue.

Caffeine's effect here is downstream. It is not reducing DHT production. It is not blocking androgen receptors. It is compensating for some of the cAMP reduction that DHT causes. This distinction matters for understanding both what caffeine can do and where its limits are.

Step 3: Microcirculation and direct follicle stimulation

Caffeine applied topically also improves local blood flow by temporarily widening small blood vessels in the scalp. Better scalp microcirculation means more oxygen and nutrients reaching follicle tissue, which is the same vascular mechanism that Minoxidil exploits at much higher potency. Caffeine's circulatory effect is weaker than Minoxidil's but additive within a multi-ingredient formula.

Additionally, research has shown that caffeine stimulates IGF-1 (insulin-like growth factor 1) activity in follicle cells. IGF-1 is a well-established promoter of hair follicle growth and inhibits follicular apoptosis. Its upregulation by caffeine adds a third distinct mechanism operating in parallel with cAMP elevation and microcirculation improvement.

Three mechanisms operating simultaneously: cAMP elevation through PDE inhibition, partial reversal of DHT's suppressive effect on follicle cell activity, and improved scalp microcirculation. For a single ingredient, that is a meaningful profile, particularly when it is functioning inside a larger formula where each active is doing something the others do not.

The Problem With Caffeine in Shampoo

One of the most important and least discussed aspects of caffeine in haircare is the delivery question. Caffeine is hydrophilic, meaning it bonds readily with water. The stratum corneum, the outermost layer of scalp skin, is lipophilic, meaning it repels water-soluble molecules. Intact scalp skin is, according to the 2025 MDPI review, virtually impenetrable to caffeine through passive diffusion.

This has a direct implication for caffeine-containing shampoos, which dominate the market in Pakistan and globally. A shampoo sits on the scalp for 60 to 90 seconds before being rinsed away. Even if caffeine were able to penetrate intact scalp skin effectively, the contact time in a shampoo application is too short for meaningful amounts to cross the barrier.

 The clinical studies showing positive hair outcomes from caffeine have used leave-on formulations, not rinse-off products, specifically because sustained contact time is necessary for the concentrations required to act on follicle biology.

Hair follicles themselves are the main entry route for caffeine into the scalp skin. The follicle canal provides a channel that bypasses the stratum corneum barrier, allowing caffeine to reach the dermal layer where follicle tissue sits. 

This is why leave-on scalp serums containing caffeine, applied to a dry scalp and left for hours, are the appropriate delivery format rather than shampoos that are rinsed away almost immediately.

Caffeine in a shampoo label is often more about consumer trust than about clinical delivery. The studies that show real follicle-level activity are using leave-on formulas at sustained contact times. That is the distinction worth knowing before choosing a product.

The Evidence Record on Topical Caffeine and Hair Loss

The 2018 non-inferiority trial

The most cited clinical study on topical caffeine for hair loss enrolled 210 men with androgenetic alopecia and compared 0.2% caffeine-based topical liquid against 5% Minoxidil solution over six months. The primary endpoint was the percentage change in the anagen hair rate, measured by trichogram. 

The caffeine group was found to be non-inferior to Minoxidil on this measure. Both groups showed significant improvements in hair loss intensity, hair shedding during combing, and hair thickness from baseline. Notably, the caffeine group also reported significant improvement in scalp itchiness, which the Minoxidil group did not.

Non-inferiority is not the same as equivalence or superiority. It means the caffeine solution performed within an acceptable margin of Minoxidil, not that it matched or exceeded it across all outcomes. The finding is clinically meaningful but should be read carefully.

The 2025 systematic review

A systematic review published in Healthcare (2025) searched PubMed, Scopus, and Web of Science for clinical trials on topical caffeine preparations for hair loss. Nine studies met the inclusion criteria, covering 684 people with androgenetic alopecia, excessive hair loss, or hair thinning. 

All nine studies reported positive outcomes for topical caffeine. However, the quality of evidence was rated medium in three studies, low in one, and very low in the remaining five, primarily because most lacked randomisation, placebo controls, or clear reporting of the caffeine concentration used.

This is the honest picture. The clinical signal for topical caffeine is consistently positive across all available studies. The methodological quality of most of those studies is not strong enough to make confident comparative claims against established pharmaceutical treatments. 

Caffeine is an ingredient with a credible mechanism and a consistently positive clinical signal, but it sits at a different level of evidence than Minoxidil or Finasteride.

The 2024 study on caffeine plus adenosine

A 2024 study published in the Journal of Cosmetic Dermatology tested a shampoo combining caffeine with adenosine in patients with hair loss. Participants showed improvement in hair density after 14 weeks of daily use. The study adds to the growing body of evidence for caffeine as a meaningful hair ingredient, though it used a combined formula which limits the ability to attribute effects specifically to caffeine.

What Caffeine Can and Cannot Do

What it can do

As a component within a well-designed multi-active formula, caffeine adds genuine biological activity that no other ingredient in the formula duplicates. It extends the anagen phase through cAMP elevation, it partially compensates for DHT's suppressive effect on follicle metabolism, it improves scalp microcirculation as a secondary mechanism, and it acts as an antioxidant against the oxidative stress that accumulates from UV exposure and pollution.

For women specifically, caffeine's anti-androgenic activity at the receptor level fills an important gap. Finasteride cannot be used in women. Caffeine provides a downstream counteraction of some of DHT's effects without pharmaceutical hormonal intervention. Combined with Melatonin's receptor-level androgen modulation, discussed in the previous article in this series, it creates a two-layer non-pharmaceutical DHT management approach within a women's formula.

What it cannot do

Caffeine cannot substitute for pharmaceutical DHT blockade in men with active pattern hair loss. It does not inhibit 5-alpha reductase. It does not reduce circulating DHT levels. Men whose hair loss is being driven aggressively by DHT will not see meaningful stabilisation from caffeine-only products. Drinking more coffee also will not help. The therapeutic concentration needs to be delivered directly to the scalp in a leave-on format, and even then, caffeine's role is supporting rather than primary in pattern hair loss. 

Caffeine in Xtra Hair Pro and Xtra Hair HER

Xtra Hair Pro: Caffeine 0.05%

Xtra Hair Pro is the mid-range men's formula: Minoxidil 6%, Finasteride 0.3%, Biotin 0.2%, and Caffeine 0.05%. Verified from the live product data.

At 0.05%, caffeine in this formula is at a concentration that adds follicle metabolic stimulation and microcirculation support on top of the primary actives. Finasteride at 0.3% is already suppressing scalp DHT by up to 75% within one month, so caffeine here is not being asked to carry the anti-androgenic load. It is supplementing the anagen extension that Minoxidil drives, adding the cAMP elevation mechanism that Minoxidil does not use, and providing an antioxidant layer alongside Biotin's structural support. This is caffeine in its appropriate role as a contributing active within a formula that has its DHT blocking done pharmaceutically. Rs. 2,849.00  per bottle.

Xtra Hair HER: Caffeine 0.2%

Xtra Hair HER contains Caffeine at 0.2%, four times the concentration in Xtra Hair Pro, alongside Minoxidil 4%, Tretinoin 0.01%, and Melatonin 0.1%. No Finasteride. Verified from the live product data.

The higher caffeine concentration in the women's formula reflects its expanded role. Without Finasteride in the formula, caffeine and Melatonin together carry the anti-androgenic function. At 0.2%, the concentration is closer to the 0.2% used in the non-inferiority trial against Minoxidil, and it is the concentration at which caffeine's PDE inhibition and downstream DHT antagonism are most clinically documented. 

For a woman dealing with PCOS-related hair loss, postpartum shedding, or early female pattern loss, caffeine at this concentration provides meaningful DHT receptor-level modulation without any of the hormonal risks that Finasteride carries.

The combination of caffeine at 0.2% with Melatonin's androgen receptor modulation and Minoxidil's vascular stimulation is the clinical logic behind why 90% of Xtra Hair HER users in consumer studies reported visibly reduced shedding within three months. 

For the full clinical picture of this formula, read Best Hair Growth Serum for Women in Pakistan. And to understand how caffeine fits into the broader context of what topical DHT management looks like without pharmaceutical intervention, the topical Finasteride guide provides the comparison.

Price: Rs.2,138.00 per bottle.

The Questions Worth Answering Directly

Does drinking more coffee prevent hair loss?

No. The concentrations of caffeine required to produce follicle-level activity in organ culture studies are far higher than what reaches the scalp through systemic absorption from drinking coffee. 

The caffeine you consume is metabolised before trace amounts reach the scalp. You would need to consume dangerously toxic quantities to approach therapeutic follicle concentrations through oral intake. Topical delivery to the scalp in a leave-on format is the only clinically supported route.

If caffeine is non-inferior to Minoxidil in one study, why is it not used as a standalone treatment?

Because the 2018 non-inferiority trial is one study with specific conditions, one formula, one population, and one primary endpoint. Non-inferiority on anagen hair rate at six months does not mean comparable outcomes across all measures, all durations, or all stages of hair loss. 

Minoxidil has decades of evidence across thousands of patients at multiple concentrations. Caffeine has nine clinical trials of varying quality. That difference in evidence base is why caffeine functions as a strong supporting ingredient and not a replacement for pharmaceutical treatment.

Why is caffeine in Xtra Hair HER at 0.2% but only 0.05% in Xtra Hair Pro?

Because they are doing different jobs. In Xtra Hair Pro, Finasteride is handling DHT suppression pharmaceutically. Caffeine supplements the anagen extension and microcirculation benefits without needing to carry the anti-androgenic load. In Xtra Hair HER, there is no Finasteride. 

Caffeine at 0.2% provides the most clinically documented level of DHT receptor-level modulation available without pharmaceutical intervention. The concentrations are calibrated to the role each ingredient is playing within its specific formula.

Are there side effects from caffeine in scalp serums?

Topical caffeine at scalp-applied concentrations has a good safety profile. The 2018 non-inferiority trial reported no significant adverse events in the caffeine group. The 2025 systematic review found minimal side effects across all nine studies. 

Some users report mild scalp tingling, which is a normal sign of increased local circulation. Systemic absorption from scalp application is low. There is no established risk of caffeine-related cardiovascular effects from topical scalp use at the concentrations used in these formulas.

TO SUM UP

The Short Version

Caffeine works on hair follicles through a mechanism that has nothing to do with its neurological stimulant effect. It inhibits phosphodiesterase, raising cAMP levels inside follicle cells and counteracting some of the growth suppression that DHT produces.

 It also improves scalp microcirculation and stimulates IGF-1 activity. The clinical evidence is consistently positive but not at the same methodological standard as the evidence for Minoxidil or Finasteride.

In practical terms, caffeine belongs in a multi-active formula where it adds biological activity that the primary actives do not cover. In Xtra Hair Pro, it complements pharmaceutical DHT blockade.

 In Xtra Hair HER, it carries part of the anti-androgenic function in a formula where Finasteride cannot be used. Neither formula is asking caffeine to do more than it can deliver, which is why it works as a genuine contributor rather than a cosmetic addition.

The key distinction between effective and ineffective caffeine products is delivery format. A leave-on scalp serum provides the contact time that follicle-level activity requires.

 A shampoo rinsed off in under two minutes does not. Both Xtra Hair Pro and Xtra Hair HER are leave-on formulas. The caffeine in both is being delivered in the format and at the contact time that science actually supports.